Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Sanara MedTech (SMTI) Revenue (2016 - 2025)

Historic Revenue for Sanara MedTech (SMTI) over the last 15 years, with Q3 2025 value amounting to $26.3 million.

  • Sanara MedTech's Revenue rose 2151.3% to $26.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $101.9 million, marking a year-over-year increase of 3055.11%. This contributed to the annual value of $86.7 million for FY2024, which is 3336.3% up from last year.
  • Latest data reveals that Sanara MedTech reported Revenue of $26.3 million as of Q3 2025, which was up 2151.3% from $25.8 million recorded in Q2 2025.
  • Over the past 5 years, Sanara MedTech's Revenue peaked at $26.3 million during Q3 2025, and registered a low of $5.0 million during Q1 2021.
  • Moreover, its 5-year median value for Revenue was $15.8 million (2023), whereas its average is $15.6 million.
  • Per our database at Business Quant, Sanara MedTech's Revenue tumbled by 2283.1% in 2021 and then soared by 12398.18% in 2022.
  • Quarter analysis of 5 years shows Sanara MedTech's Revenue stood at $7.0 million in 2021, then skyrocketed by 117.76% to $15.3 million in 2022, then grew by 15.5% to $17.7 million in 2023, then skyrocketed by 48.7% to $26.3 million in 2024, then increased by 0.11% to $26.3 million in 2025.
  • Its Revenue stands at $26.3 million for Q3 2025, versus $25.8 million for Q2 2025 and $23.4 million for Q1 2025.